Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons
Mokhbat, J.E.; Naman, R.E.; Rahme, F.S.; Farah, A.E.; Zahar, K.L.; Maalouf, A.
Le Journal Medical Libanais. Lebanese Medical Journal 38(1): 9-14
1989
ISSN/ISBN: 0023-9852 PMID: 2519339 Document Number: 337083
A group of 64 multitransfused individuals with hemophilia or congenital hemolytic anemias were tested for antibodies against the human immunodeficiency virus. Thirty five of them were also evaluated clinically and their blood products supply was investigated. Only four hemophiliacs were found to be seropositive. The major risk factor that seemed associated with the acquisition of the virus was the transfusion of lyophilized factor VIII concentrate imported from the USA. A suggestion for control of transfusion associated infection and of contamination of hemophiliacs is presented.
Document emailed within 1 workday
Related Documents
Weber, R.; Ledergerber, B.; Zbinden, R.; Altwegg, M.; Pfyffer, G.E.; Spycher, M.A.; Briner, J.; Kaiser, L.; Opravil, M.; Meyenberger, C.; Flepp, M. 1999: Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study Archives of Internal Medicine 159(13): 1473-1480Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Madge, S.; Phillips, A.N.; Griffioen, A.; Olaitan, A.; Johnson, M.A. 1998: Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV International Journal of Epidemiology 27(6): 1068-1071
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Solomon, S.S.; Celentano, D.D.; Srikrishnan, A.K.; Vasudevan, C.K.; Murugavel, K.G.; Iqbal, S.H.; Anand, S.; Kumar, M.S.; Latkin, C.; Solomon, S.; Mehta, S.H. 2010: Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India American Journal of Epidemiology 172(11): 1259-1267
Joshi, S.Kumar.; Ghimire, G.R. 2003: Serological prevalence of antibodies to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among healthy Nepalese males--a retrospective study Kathmandu University Medical Journal 1(4): 251-255
Jentzsch, K.D.; Apostoloff, E. 1970: Human susceptibility to herpesvirus suis (Aujeszky-virus). 4. Serological determinations in persons in infection endangered occupational groups Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 16(9): 692-696
Ladep, N.G.; Agaba, P.A.; Agbaji, O.; Muazu, A.; Ugoagwu, P.; Imade, G.; Cooke, G.; McCormack, S.; Taylor-Robinson, S.D.; Idoko, J.; Kanki, P. 2013: Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort World Journal of Gastroenterology 19(10): 1602-1610
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Kiwanuka, N.; Laeyendecker, O.; Robb, M.; Kigozi, G.; Arroyo, M.; McCutchan, F.; Eller, L.A.; Eller, M.; Makumbi, F.; Birx, D.; Wabwire-Mangen, F.; Serwadda, D.; Sewankambo, N.K.; Quinn, T.C.; Wawer, M.; Gray, R. 2008: Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection Journal of Infectious Diseases 197(5): 707-713
Zierler, S.; Mayer, K.; Moore, J.; Stein, M.; Schoenbaum, E.; Schuman, P.; Rompalo, A. 1999: Sexual practices in a cohort of US women with and without human immunodeficiency virus. HERS Study. HIV Epidemiology Research Study Journal of the American Medical Women's Association 54(2): 79-83
Gabrilovich, D.I.; Vasilev, V.B.; Nosikov, V.V.; Serebrovskaia, L.V.; Shepeleva, G.K.; Ivanova, L.A.; Pokrovskiĭ, V.V. 1995: The presence of HIV DNA in the neutrophils of persons infected with the human immunodeficiency virus and the clinical parallels of this phenomenon Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 52-55
Chong, C.Y.; Ng, W.Y.; Leo, Y.S.; Se-Thoe, S.Y.; Ling, A.E.; Chan, K.P. 2001: Prevention of human immunodeficiency virus (HIV) transmission from mother to child--a cohort study in Singapore Annals of the Academy of Medicine Singapore 30(4): 387-392
Li, J.-y.; Li, L.; Li, H.; Bao, Z.-y.; Li, H.-p.; Wang, Z.; Zhuang, D.-m.; Liu, Y.-j.; Liu, S.-y. 2006: Cohort study on human immunodeficiency virus discordant couples in the countryside of central China Zhonghua Liu Xing Bing Xue Za Zhi 27(3): 192-195
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Teira, R.; Virosta, M.; Muñoz, J.; Zubero, Z.; Cisterna, R.; Santamaría, J.M. 1997: Historical cohort study on bacterial pneumonias as predictors of the progression of the human immunodeficiency virus disease Enfermedades Infecciosas y Microbiologia Clinica 15(8): 418-421
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51